The stock has found support at its 50-day SMA, and is only 40% above its 200 SMA. IBD's analysts would say that these facts are encouraging. Any stock that is up nearly 400% in 12 months needs to take a rest. If the 50-day line continues to hold, and the stock doesn't get to a price that is more than 100% above its 200 day SMA, it can resume its climb, if fundamentals remain positive. The percentage of the US population over the age of 75 continues to soar. That is ADUS' market. Fear Not!